After laser, Ultrasound and IPL, Plexr® comes as a new and less invasive modality to the ophthalmic world. GMV is proud to be the first and pioneer manufacturer of the unique Plasma technology used in the field of ophthalmology.
The safety of plasma treatment with Plexr® at ocular surface has been clinically demonstrated in an animal study and this study was published in the Journal of Clinical Plasma Medicine. This patented technology offers an alternative to invasive surgical procedures, reducing recovery time and any complications that can arise before and after surgery and so is as an innovative development in aesthetic medicine and rejuvenating treatments by utilizing Plexr®. In addition, in this technology heat is not spreading to the surrounding area, meaning it is perfect to operate on areas (such as eyelids), that are not suitable for other devices like radiofrequency scalpels or lasers (Nejat et al, 2019). Plexr® has the potential to be used as an alternative method for treatment of some of the ocular surface disorders without needing to conventional surgical procedures.
This innovative project, called “PANIS Method”, has been developed by the research group of Iranian Vision Research Center. The aim is to introduce a new treatment method, working on precise guide line for best and most effective office-based technique in applying plasma for treatment of a number of ocular surface disorders.
PANIS is abbreviation of: Plasma Assisted Non Invasive Surgery. (Panis in iranian language means SWEET and is iranian girl name).
Currently Plexr® is used in treatment of following ophthalmic disorders:
Versatility
Plexr® can work completely safety and effectively both on skin and on ocular surface, as scientifically proven and published on international literature
Non-surgical
do not need to take the patient to the operating room (completely office-based). There is no need of anesthesia or stitches.
Low cost
compared to classical treatments
From the first time I started working with Plexr my mind focused on the idea that I could use this technology to treat superficial eye diseases, but at that time there was no were scientific studies published on the therapeutic application of plasma for these pathologies in the literature
Atoms are the elements of molecules; when the interaction among molecules is high, they result in a solid, able to maintain shape a volume until an extremely high strength can break such interaction. When the interaction is weak among molecules, this can result respectively in a liquid, maintaining volume but losing shape, or in a gas, which maintains no shape or volume, but occupies all the available space. When an external energy can split the molecules of the gas in positive and negative parts, we reached the fourth state of the matter: plasma.
When activated, Plexr ionizes the air between the tip of the device and the human body by generating an appropriate potential difference. The electric breakdown of the air is around 3000 V per mm, depending from some factors such as humidity and bodies the physical phenomenon is generated by. Using the Plexr signal parameters, around half millimetre is the needed distance for the ionization of the air atoms. No plasma is generated when the probe is in direct contact with the tissue or too distant from it.
The duration of the treatment varies depending on the type of operation to be performed, but never more than 30 minutes, time required for non-surgical blepharoplasty. Other treatments, such as pterygium, require only a few minutes.
The results are immediately visible and absolutely lasting over time. For some types of treatment, more than one session may be necessary to maximize the effectiveness of the result.
There are no permanent side effects for treatments performed with Plexr by experienced and trained doctors, as clinically proven also by scientific publications. However, it is recommended that the post-treatment instructions provided by the doctor be strictly followed.
Contact us for more information
"*" indicates required fields
GMV srl
Legal and operative headquarter:
Via Roberto Paribeni 37
00173, Rome (IT)
VAT Number: IT09449991000
Pursuant to the new guidelines of the Ministry of Health of 03/28/2013, relating to health advertising concerning medical devices, the user is advised that the information contained therein is intended exclusively for professional operators.
"*" indicates required fields
Italy
Spain
France
Rest of europe
Oceania
North America
South America
Asia
Africa
Italy
Spain
France
Rest of europe
Oceania
North America
South America
Asia
Africa
